Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RISING

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 49
  • 0 comments

FDA approve DICYCLOMINE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 64
  • 0 comments

FDA approve MIDAZOLAM HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 65
  • 0 comments

FDA approve IPRATROPIUM BROMIDE

Comment Full text

J AND J CONSUMER INC

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 62
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE

Comment Full text

SHANDONG XINHUA

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 71
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

SHILPA

  • FDA Approval
  • Nov. 19, 2024, 09:40 UTC
  • 58
  • 0 comments

FDA approve PEMETREXED DISODIUM

Comment Full text

NANJING KING-FRIEND

  • FDA Approval
  • Nov. 19, 2024, 05:11 UTC
  • 75
  • 0 comments

FDA approve CYANOCOBALAMIN

Comment Full text

ELITE LABS INC

  • FDA Approval
  • Nov. 19, 2024, 05:11 UTC
  • 63
  • 0 comments

FDA approve LISDEXAMFETAMINE DIMESYLATE

Comment Full text

SYNDAX PHARMACEUTICALS INC

  • FDA Approval
  • Nov. 18, 2024, 14:30 UTC
  • 60
  • 0 comments

FDA approve REVUMENIB

Comment Full text

ACELLA

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 46
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text
  • Previous
  • 312
  • 313
  • 314
  • 315
  • 316
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158458)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin